Iranian Journal of Parasitology 2018. 13(1):39-48.

Identification of Antigenic and Immunogenic Proteins of Toxoplasma gondii in Human and Sheep by Immunoprote-omics
Mohammad Taghi AHADY, Nasser HOGHOOGHI-RAD, Rasool MADANI, Reza ESMAEILI RASTAGHI

Abstract


Background: Toxoplasmosis is a parasitic disease caused by the intracellular protozoan parasite, Toxoplasma gondii, which can infect humans and warm-blooded animals. This infection can lead to still birth and abortion among some susceptible hosts especially sheep and human in pregnancy. Development of a vaccine against T. gondii infection is very important-especially for use in immunocompromised patients, pregnant women, and sheep. Different antigens of T. gondii can be potential candidates for immunization. The aims of this study were to identify the immunodominant and antigenic proteins of T. gondii in sheep and man.

Methods: Tachyzoites’ proteins were separated by two-dimensional polyacrylamide gel electrophoresis (2-DE), and subjected to western blot analysis probed with T. gondii positive sera of sheep and human (Biotechnology Department of Pasteur Institute of Tehran, Iran, from April 2016 to March 2017). Finally, the immunoreactive proteins were identified by mass spectrometry (MALDI-TOF/MS and MS/MS) technique.

Results: Five immunoreactive and antigenic proteins were recognized by Toxoplasma positive sera of human and sheep. These identified proteins were Enolase 2, rhoptry protein 4 (ROP4), dense granular protein 14 (GRA14), rhoptry protein 15 (ROP15) and rhoptry protein 9 (ROP9).

Conclusion: The identified immunodominant proteins have potential to be used as diagnostic antigens and as diagnostic markers of Toxoplasma infection in sheep and human.

Keywords


Toxoplasma gondii; Antigens; Immunoproteomics; Enolase; Rhoptry’s proteins; GRA14

Full Text:

PDF

References


Dubey JP. Toxoplasmosis of animals and humans, Second Edition. Taylor & Francis Group, CRC Press, 2010.

Boothroyd JC. Toxoplasma gondii: 25 years and 25 major advances for the field. Int J Parasitol. 2009; 39(8):935-46.

Lim SS, Othman RY. Recent Advances in Toxoplasma gondii Immunotherapeutic. Ko-rean J Parasitol. 2014;52(6):581-93.

Daryani A, Sharifi M, Ziaei H, Sarvi S, Ahmadpour E. Toxoplasma gondii: A Review of Excretory Secretory Antigens. J Mazand Univ Med Sci. 2013; 23 (Suppe-2) 220-232.

Zheng B, Lu S, Tong Q, Kong Q, Lou D. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vac-cine candidate against toxoplasmosis in mice. Vaccine. 2013;31(41):4578-84.

Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F. Toxoplasma gondii: Pro-teomic analysis of antigenicity of soluble tachyzoite antigen. Exp Parasitol.2009; 122(1):41-6.

Sun XM1, Ji YS, Elashram SA, Lu ZM, Liu XY, Suo X, Chen QJ, Wang H. Identi-fication of antigenic proteins of Toxoplasma gondii RH strain recognized by human im-munoglobulin G using immunoproteomics. J Proteomics. 2012; 77:423-32.

Gómez de León CT, Díaz Martín RD, Mendoza Hernández G, González Pozos S, Ambrosio JR, Mondragón Flores R. Proteomic characterization of the subpel-licular cytoskeleton of Toxoplasma gondiita chyzoites. J Proteomics. 2014; 111:86-99.

Marques PX, O'Donovan J, Williams EJ et al. Detection of Toxoplasma gondii antigens reactive with antibodies from serum, am-niotic, and allantoic fluids from experi-mentally infected pregnant ewes. Vet Para-sitol.2012;185(2-4):91-100.

Arab-Mazar Z, Seyyed-Tabaei SJ, Mirah-madi H. Cloning of Dense Granular7 (GRA7) Gene of Toxoplasma gondii into pTZ57RT Vectors. Novel Biomed. 2014; 2 (4): 114-119.

Arab-Mazar Z, Fallahi S, Koochaki A, Haghighi A, Seyyed Tabaei SJ. Immunodi-agnosis and molecular validation of Toxo-plasma gondii-recombinant dense granular (GRA) 7 protein for the detection of tox-oplasmosis in patients with cancer. Micro-biol Res.2016; 183:53-9.

Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H. Toxo-plasma gondii: The vaccine potential of three trivalent antigen-cock tails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplas-mosis in BALB/c mice. Exp Parasi-tol.2012; 131(1):133-8.

Jalallou N, Bandehpour M, Khazan H, Haghighi A, Kazemi B. Evaluation of Re-combinant SAG1 Protein for Detection of Toxoplasma gondii Immunoglobulin M by ELISA Test. Iran J Parasitol. 2012; 7(3):1-9.

Selseleh MM, Keshavarz H, Mohebali M, Shojaee S, Modarressi M, Eshragian M, Selseleh MM. Production and Evaluation of Toxoplasma gondii Recombinant Surface Antigen 1 (SAG1) for Serodiagnosis of Acute and Chronic Toxoplasma Infection in Human Sera. Iran J Parasitol. 2012; 7 (3):1-9.

Bittame A, Effantin G, Pètre G et al. Toxo-plasma gondii: Biochemical and biophysical characterization of recombinant soluble dense granule proteins GRA2 and GRA6. Biochem Biophys Res Commun. 2015;459(1):107-12.

Besteiro S, Michelin A, Poncet J, Du-bremetz JF, Lebrun M. Export of a Toxo-plasma gondii rhoptry neck protein complex at the host cell membrane to from the moving junction during invasion. PLoS Pathog. 2009; 5(2):e1000309.

Straub KW, Cheng SJ, Sohn CS, Bradley PJ. Novel components of the Apicom-plexan moving junction reveal conserved and coccidian-restricted elements. Cell Mi-crobiol. 2009; 11(4):590-603.

Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection a polymorphic kinase homologue. Nature. 2007; 445(7125):324-7.

Yamamoto M, Standley DM, Takashima S et al. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J Exp Med. 2009; 206(12):2747-60.

Camejo A, Gold DA, Lu D et al. Identifi-cation of three novel Toxoplasma gondii rhoptry proteins. Int J Parasitol. 2004; 44(2):147-60.

Hester J, Mullins J, Sa Q, Payne L, Mercier C, Cesbron-Delauw MF, Suzuki Y. Toxo-plasma gondii Antigens Recognized by IgG Antibodies Differ between Mice with and without Active Proliferation of Tachyzoites in the Brain during the Chronic Stage of Infection. Infect Immun. 2012; 80(10):3611-20.

Aubert D, Maine GT, Villena I, Hunt JC, Howard L, Sheu M, Brojanac S, Chovan LE, Nowlan SF, Pinon JM. Recombinant antigens to detect Toxoplasma gondii specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunology. J Clin Microbiol. 2000; 38(3):1144-50.

Drapała D, Holec-Gąsior L, Kur J. New recombinant chimeric antigens, P35-MAG1, MIC1-ROP1, and MAG1-ROP1, for the serodiagnosis of human toxo-plasmosis. Diagn Microbiol Infect Dis. 2015; 82(1):34-9.

Pietkiewicz H, Hiszczyńska-Sawicka E, Kur J, Petersen E et al. Usefulness of Toxoplas-ma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol. 2004; 42(4):1779-81.

Holec L, Gasior A, Brillowska-Dabrowska A, Kur J. Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein (MIC1) for detection of immuno-globulin G antibodies. Exp Parasitol. 2008; 119(1):1-6.

Holec-Gasior L, Kur J. Toxoplasma gondii: Recombinant GRA5 antigen for detection of immunoglobulin G antibodies using enzyme-linked immunosorbent assay. Exp Parasitol. 2010; 124(3):272-8.

Jiang W, Xue JX, Liu YC, Li T et al. Iden-tification and characterization of an immu-nogenic antigen, enolase2, among excreto-ry/secretory antigens (ESA) of Toxoplasma gondii. Protein Expr Purif. 2016; 127:88-97.

Coligan JE, Dumn BM, Speicher DW, Wingfield PT. Short protocols in protein science. John Wiley & Sons Inc. 2003.

Wu XN, Lin J, Lin X, Chen J, Chen ZL, Lin JY. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 Primes: anti-Toxoplasma immune re-sponse in mice. Parasitol Res. 2012; 111(5):2001-9.

Hiszczyńska-Sawicka E, Olędzka G, Holec-Gąsior L et al. Evaluation of im-mune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6, and GRA7 antigens of Toxoplasma gondii. Vet Parasitol. 2011; 177(3-4):281-9.

Xue M, He S, Cui Y, Yao Y, Wang H. Evaluation of the immune response elicit-ed by multi-antigenic DNA vaccine ex-pressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitol Int. 2008; 57(4):424-9.

Sánchez VR, Pitkowski MN, Fernández Cuppari AV et al. Comnination of CPG-oligodeoxynucleotides with recombinant ROP2 0r GRA4 proteins induces protec-tive immunity against Toxoplasma gondii in-fection. Exp Parasitol. 2011; 128(4):448-53.

Sun XM, Zou J, A A ES, Yan WC, Liu XY, Suo X, Wang H, Chen QJ. DNA vac-cination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasit Vectors. 2011; 4:213.

Li WS, Chen QX, Ye JX, Xie ZX, Chen J, Zhang LF. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion an-tigen ROP2 and SAG1 from Toxoplasma gondii in mice: Cellular and humoral im-mune responses. Parasitol Res. 2011; 109(3):637-44.

Yuan ZG, Zhang XX, He XH E et al. Protective immunity induced by Toxoplasma gondiirhoptry protein 16 against toxoplas-mosis in mice. Clin Vaccine Immu-nol.2011; 18(1):119-24.

Qu D, Han J, Du A. Evaluation of protectiveeffect of multiantigenic DNA vaccine encoding MIC3 and ROP18 anti-gen segments of Toxoplasma gondii in mice. Parasitol Res. 2013; 112(7):2593-9.

Yuan ZG, Zhang XX, Lin RQ et al. Pro-tective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine. 2011; 29(38):6614-9.

Hiszczyńska-Sawicka E, Li H, Boyu Xu J et al. Induction of immune responses in sheep by vaccination with liposome en-trapped DNA complexes encoding Toxo-plasma gondii MIC3 gene. Pol J Vet Sci.2012; 15(1):3-9.

Fang R, Feng H, Hu M et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol.2012; 187(1-2):140-6.

Peng GH, Yuan ZG, Zhou DH et al. Tox-oplasma gondiimicroneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine. 2009; ;27(47):6570-4.

Liu Q, Gao S, Jiang L et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudora-bies in BALB/c mice. Microbes In-fect.2008; 10(12-13):1355-62.

Qu D, Yu H, Wang S, Cai W, Du A. In-duction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vet Par-asitol. 2009; 166(3-4):220-7.

Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination induced resistance to virulent Toxoplasma gondii. In-fect Immun. 2000; 68(3):1026-33.

Siachoque H, Guzman F, Burgos J, Patar-royo ME, Gomez Marin JE. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Par-asitol. 2006; 114(1):62-5.

Carey KL, Jongco AM, Kim K, Ward GE. The Toxoplasma gondii Rhoptry Protein ROP4 is Secreted into Parasitophorous Vacuole and Becomes Phosphorylated in Infected Cells. Eukaryot Cell. 2004; 3(5):1320-30.

Gatkowska J, Dziadek B, Brzostek A, Dzi-adek J, Dzitko K, Długońska H. Determi-nation of Diagnostic Value of Toxoplasma gondii Recombinant ROP2 and ROP4 An-tigens in Mouse Experimental Model. Pol J Microbiol. 2010; 59(2):137-41.

Dziadek B, Gatkowska J, Brzostek A, Dzi-adek J, Dzitko K, Dlugonska H. Toxoplas-ma gondii: The immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol.2009; 123(1):81-9.

Cesbron-Delauw MF, Guy B, Torpier G et al. Molecular characterization of a 23-kilodalton major antigen secreted by Toxo-plasma gondii. Proc Natl Acad Sci U S A. 1989; 86(19):7537-41.

Rome ME, Beck JR, Turetzky JM, Webster P, Bradley PJ. Inter-vacuolar transport and unique topology of GRA14, a novel dense granule protein in Toxoplasma gondii. Infect Immun. 2008; 76(11):4865-75.

Wang JL, Li TT, Elsheikha HM et al. Functional Characterization of RhoptryKi-nome in the Virulent Toxoplasma gondii RH Strain. Front Microbiol. 2017; 8:84.

Reichmann G, Długońska H, Fischer HG. Characterization of TgROP9 (P36), a novel rhoptry protein of Toxoplasma gondii tachyzoites identified by T cell clone. Mol Biochem Parasitol. 2002; 119(1):43-54.

Lebrun M, Carruthers Vern B, Cesbron-Delauw MF. Toxoplasma gondii, Second Edi-tion, Chapter 12. Elsevier Ltd. 2014: 389-453.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.